Works matching IS 09255710 AND DT 2024 AND VI 120 AND IP 1
Results: 20
Chemotherapy-induced aseptic thrombophlebitis with an air bubble in the thrombus.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Current progress of CAR-T-cell therapy for patients with multiple myeloma.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 1, p. 15, doi. 10.1007/s12185-024-03794-0
- By:
- Publication type:
- Article
Novel treatment strategies for hematological malignancies in the immunotherapy era.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Novel CAR T cell therapies for patients with large B cell lymphoma.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 1, p. 6, doi. 10.1007/s12185-024-03792-2
- By:
- Publication type:
- Article
A review of the Augustine blood group system.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 1, p. 44, doi. 10.1007/s12185-024-03791-3
- By:
- Publication type:
- Article
Reply to the Dr. Murphy's comment.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Post-transfusion purpura and adult primary thrombocytopenia.
- Published in:
- 2024
- By:
- Publication type:
- Letter
Evolution of natural killer cell-targeted therapy for acute myeloid leukemia.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 1, p. 34, doi. 10.1007/s12185-024-03778-0
- By:
- Publication type:
- Article
Mendelian randomization reveals association of gut microbiota with Henoch–Schönlein purpura and immune thrombocytopenia.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 1, p. 50, doi. 10.1007/s12185-024-03777-1
- By:
- Publication type:
- Article
Ruxolitinib in steroid-refractory acute graft-vs-host disease: Japanese subgroup analysis of the randomized REACH2 trial.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 1, p. 106, doi. 10.1007/s12185-024-03772-6
- By:
- Publication type:
- Article
Clinical features of immature leukemias in children.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 1, p. 117, doi. 10.1007/s12185-024-03771-7
- By:
- Publication type:
- Article
Cytomegalovirus infection during daratumumab therapy in patients with newly diagnosed multiple myeloma.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 1, p. 91, doi. 10.1007/s12185-024-03770-8
- By:
- Publication type:
- Article
An unfavorable and a successful pregnancy outcome during and after treatment of gamma heavy chain disease.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 1, p. 135, doi. 10.1007/s12185-024-03769-1
- By:
- Publication type:
- Article
Bernard–Soulier syndrome caused by a novel GP1BB variant and 22q11.2 deletion.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 1, p. 142, doi. 10.1007/s12185-024-03768-2
- By:
- Publication type:
- Article
Bispecific antibodies for multiple myeloma: past, present and future.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 1, p. 23, doi. 10.1007/s12185-024-03766-4
- By:
- Publication type:
- Article
Spontaneous regression of multiple solitary plasmacytoma harboring Epstein–Barr virus: a case report and literature review.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 1, p. 128, doi. 10.1007/s12185-024-03765-5
- By:
- Publication type:
- Article
A phase 2, open-label study of ibrutinib plus rituximab in Japanese patients with Waldenstrom's macroglobulinemia.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 1, p. 80, doi. 10.1007/s12185-024-03761-9
- By:
- Publication type:
- Article
Efficacy of daratumumab in newly diagnosed multiple myeloma patients with 1q21 gain.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 1, p. 71, doi. 10.1007/s12185-024-03760-w
- By:
- Publication type:
- Article
Changes in chronic myeloid leukemia treatment modalities and outcomes after introduction of second-generation tyrosine kinase inhibitors as first-line therapy: a multi-institutional retrospective study by the CML Cooperative Study Group.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 1, p. 60, doi. 10.1007/s12185-024-03758-4
- By:
- Publication type:
- Article
Optimized BEAC conditioning regimen improves clinical outcomes of autologous hematopoietic stem cell transplantation in non-Hodgkin lymphomas.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 1, p. 96, doi. 10.1007/s12185-024-03755-7
- By:
- Publication type:
- Article